Article ; Abstract ; INTRODUCTION ; NEW NOMENCLATURE ; EPIDEMIOLOGY, NATURAL HISTORY, AND BURDEN OF DISEASE ; PATIENTS WITH T2DM: AN IMPORTANT TARGET GROUP FOR DETECTION OF ADVANCED LIVER FIBROSIS ; LIFESTYLE INTERVENTION IS THE CORNERSTONE IN THE MANAGEMENT OF MASLD ; CARDIOVASCULAR DISEASE RISK REDUCTION ; MASLD AND ANTI-HYPERGLYCEMIC DRUGS
TE-LSM can be used to differentiate PSVD from compensated cirrhosis. Pathological features in association with increased liver stiffness are identified.
주제 인용 현황 ; 논문 간 인용 데이터를 분석하여, 이 논문이 어떤 주제에서 활용 되었는지 확인합니다. 이 논문을 인용한 논문 수와 인용 주제 변화 추이를 비교해 보세요!
Summary Cirrhosis is characterized by fibrosis and nodule formation. It is the end stage of many different diseases affecting the liver and is usually irreversible. Cirrhotic patients may be compen...
Patients with chronic liver disease progressed to compensated advanced chronic liver disease (cACLD), the risk of liver-related decompensation increased significantly. This study aimed to develop p...
한빛사 · 129건 ; 이순규(가톨릭대학교 의과대학) ; 김기애(경희대학교, 내과) ; 김미나(연세대학교 의과대학) ; 권윤(Heidelberg University) ; 이예리(한양대학교 의과대학) ; 김승업(연세대학교 의과대학) ; 권혜미(울산대학교 의과대학, 서울아산병원) ; 정윤석(전남대학교) ; 민병현(한림대학교) ; Haushabhau S. Pagire(GIST)
blood Bilirubin / blood Blood Proteins Blood Sedimentation Humans Leucyl Aminopeptidase / blood Liver / drug effects* Liver Cirrhosis / drug therapy* Liver Function Tests Placebos Thymol
The Journal of Gastroenterology and Hepatology publishes digestive and liver disease research in the fields of gastroenterology, hepatology and endoscopy.
Patients with type 2 diabetes (T2D) are at risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD). We investigated the prevalence of compensated advanced chronic liver...
well compensated liver disease. The etiology of fulminant hepatic failure refers to a wide variety of causes, of which toxin-induced or viral hepatitis are most common. In spite of specific...